Log in
Enquire now
‌

US Patent 10196351 Sulfide alkyl compounds for HBV treatment

Patent 10196351 was granted and assigned to Novira Therapeutics on February, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Novira Therapeutics
Novira Therapeutics
0
Current Assignee
Novira Therapeutics
Novira Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
101963510
Patent Inventor Names
Jason Jacintho0
Yalda Bravo0
Ryan C. Clark0
Austin Chen0
Bijan Pedram0
Nicholas Stock0
Date of Patent
February 5, 2019
0
Patent Application Number
154162220
Date Filed
January 26, 2017
0
Patent Citations Received
‌
US Patent 10710959 Sulfide alkyl compounds for HBV treatment
Patent Primary Examiner
‌
Rebecca L Anderson
0
Patent abstract

The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10196351 Sulfide alkyl compounds for HBV treatment

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.